KK

Kamal Kant

Active Director Designated Partner DIN 09220584
DIN 09220584 First appointment Jun 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamal Kant

Data last updated:

Kamal Kant is a Designated Partner at Medicea Gen Biotech Llp (since 2021). The company operates in Pharma.

DIN 09220584
Primary Designation Designated Partner
Industry Pharma
First Appointment 29 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Jun 20212021Active

Board colleagues of Kamal Kant

NameDINCompanyDesignation
Akhil Pruthi07204182Medicea Gen Biotech LlpDesignated Partner
Rachna Chugh09220585Medicea Gen Biotech LlpDesignated Partner
Rahul Jain06796392Medicea Gen Biotech LlpDesignated Partner
Vipul Jain06509892Medicea Gen Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medicea Gen Biotech Llp
Premium access

Shareholding and investment profile for Kamal Kant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamal Kant

Kamal Kant currently holds 1 directorship: Medicea Gen Biotech Llp (Designated Partner, since 29 Jun 2021).

Kamal Kant was first appointed on 29 Jun 2021 as Designated Partner at Medicea Gen Biotech Llp.

The current boards of Kamal Kant's companies include Akhil Pruthi (Medicea Gen Biotech Llp), Rachna Chugh (Medicea Gen Biotech Llp), Rahul Jain (Medicea Gen Biotech Llp), Vipul Jain (Medicea Gen Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available